Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: Influence of nitric oxide and of insulin resistance

Medicine & Life Sciences

• Vascular Smooth Muscle 96%
• Smooth Muscle Myocytes 86%
• Vascular Endothelial Growth Factor A 84%
• Insulin Resistance 80%
• Nitric Oxide 79%
• Insulin 66%
• phosphatidylinositol 4,5-biphosphate kinase 41%
• Zucker Rats 33%
• Mitogen-Activated Protein Kinases 24%
• Wortmannin 20%
• 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one 19%
• Nitric Oxide Synthase 15%
• Insulin, Regular, Human 13%
• Proteins 11%
• 8-bromocyclic GMP 11%
• omega-N-Methylarginine 11%
• Cyclic GMP-Dependent Protein Kinases 10%
• Guanosine 10%
• Nitric Oxide Donors 9%
• 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 9%
• Nitroprusside 9%
• Arterioles 8%
• Protein Kinase Inhibitors 8%
• Vascular Resistance 7%
• Aorta 7%
• Animal Models 5%
• Enzyme-Linked Immunosorbent Assay 5%
• Western Blotting 5%

Chemical Compounds

• Insulin Derivative 100%
• Nitric Oxide 92%
• Resistance 61%
• Phosphatidylinositol 44%
• Wortmannin 41%
• Protein 35%
• LY294002 22%
• EC 2.7.12.2 (Mitogen-Activated Protein Kinase Kinase) Inhibitor 19%
• Nitric Oxide Synthase Inhibitor 18%
• Sodium Nitroprusside 17%
• Nitric Oxide Donor 17%
• Guanosine 13%
• Metabolic 9%